These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 32459694)

  • 1. The role of glutamate receptors and their interactions with dopamine and other neurotransmitters in the development of tardive dyskinesia: preclinical and clinical results.
    Szota AM; Scheel-Krüger J
    Behav Pharmacol; 2020 Sep; 31(6):511-523. PubMed ID: 32459694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopamine and N-methyl-D-aspartate receptor interactions in the neostriatum.
    Cepeda C; Levine MS
    Dev Neurosci; 1998; 20(1):1-18. PubMed ID: 9600386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tardive dyskinesia: Who gets it and why.
    Frei K
    Parkinsonism Relat Disord; 2019 Feb; 59():151-154. PubMed ID: 30522959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Markers of glutamatergic neurotransmission and oxidative stress associated with tardive dyskinesia.
    Tsai G; Goff DC; Chang RW; Flood J; Baer L; Coyle JT
    Am J Psychiatry; 1998 Sep; 155(9):1207-13. PubMed ID: 9734544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deficient striatal adaptation in aminergic and glutamatergic neurotransmission is associated with tardive dyskinesia in non-human primates exposed to antipsychotic drugs.
    Lévesque C; Hernandez G; Mahmoudi S; Calon F; Gasparini F; Gomez-Mancilla B; Blanchet PJ; Lévesque D
    Neuroscience; 2017 Oct; 361():43-57. PubMed ID: 28790021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Animal models of tardive dyskinesia--a review.
    Kulkarni SK; Naidu PS
    Indian J Physiol Pharmacol; 2001 Apr; 45(2):148-60. PubMed ID: 11480221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tardive Dyskinesia-like Syndrome Due to Drugs that do not Block Dopamine Receptors: Rare or Non-existent: Literature Review.
    D'Abreu A; Friedman JH
    Tremor Other Hyperkinet Mov (N Y); 2018; 8():570. PubMed ID: 30191087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tardive dyskinesia: pathophysiology and animal models.
    Casey DE
    J Clin Psychiatry; 2000; 61 Suppl 4():5-9. PubMed ID: 10739324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The neurobiology of schizophrenia.
    Littrell RA; Schneiderhan M
    Pharmacotherapy; 1996; 16(6 Pt 2):143S-147S; discussion 166S-168S. PubMed ID: 8947997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glutamate-dopamine interactions in the basal ganglia: relationship to Parkinson's disease.
    Greenamyre JT
    J Neural Transm Gen Sect; 1993; 91(2-3):255-69. PubMed ID: 8099800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significance of dysfunctional glutamatergic transmission for the development of psychotic symptoms.
    Pietraszek M
    Pol J Pharmacol; 2003; 55(2):133-54. PubMed ID: 12926541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetics of tardive dyskinesia: Promising leads and ways forward.
    Zai CC; Maes MS; Tiwari AK; Zai GC; Remington G; Kennedy JL
    J Neurol Sci; 2018 Jun; 389():28-34. PubMed ID: 29502799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathophysiologic basis of tardive dyskinesia.
    Baldessarini RJ; Tarsy D
    Adv Biochem Psychopharmacol; 1980; 24():451-5. PubMed ID: 6105793
    [No Abstract]   [Full Text] [Related]  

  • 14. [Prevention and treatment of tardive dyskinesia caused by antipsychotic drugs].
    Seigneurie AS; Sauvanaud F; Limosin F
    Encephale; 2016 Jun; 42(3):248-54. PubMed ID: 26922134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct receptor cross-talk can mediate the modulation of excitatory and inhibitory neurotransmission by dopamine.
    Lee FJ; Wang YT; Liu F
    J Mol Neurosci; 2005; 26(2-3):245-52. PubMed ID: 16012198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antipsychotic-induced tardive syndromes].
    Fleischhacker WW; Hofer A; Jagsch C; Pirker W; Psota G; Rittmannsberger H; Seppi K
    Neuropsychiatr; 2016 Sep; 30(3):123-130. PubMed ID: 27580887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tardive dyskinesia is associated with altered putamen Akt/GSK-3β signaling in nonhuman primates.
    Hernandez G; Mahmoudi S; Cyr M; Diaz J; Blanchet PJ; Lévesque D
    Mov Disord; 2019 May; 34(5):717-726. PubMed ID: 30675935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacogenetics of tardive dyskinesia: an updated review of the literature.
    Lanning RK; Zai CC; Müller DJ
    Pharmacogenomics; 2016 Aug; 17(12):1339-51. PubMed ID: 27469238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An update on tardive dyskinesia.
    Simpson GM; Pi EH; Sramek JJ
    Hosp Community Psychiatry; 1986 Apr; 37(4):362-9. PubMed ID: 2870977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antipsychotic-induced Tardive dyskinesia: from biological basis to clinical management.
    Salem H; Pigott T; Zhang XY; Zeni CP; Teixeira AL
    Expert Rev Neurother; 2017 Sep; 17(9):883-894. PubMed ID: 28750568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.